Close Menu

Grants

Additional funding opportunities

Research Funding Opportunities

Tools to Find Funding

Grants Awarded for Health Sciences Research

Titlesort descending Type $ Amount Activity Investigator Unit Sponsor Date
A Prospective Multicenter Randomized Controlled Clinical Study to Investigate the Safety and Effectiveness of the RECELL System Combined with Meshed Autograft for Reduction of Donor Skin Harvesting Contract $229,008.88 Clinical Trial Lourdes Castanon Surgery Avita Medical Americas, LLC 01/2021
A Prospective, Multi-center, Single Arm Study to Obtain “Real World” Clinical Data and Characterize the Acute and Long-term Performance of the Micrusframe and Galaxy Coils for the Endovascular Treatment Contract $109,963.64 Clinical Trial Mohammad El-ghanem Neurology Cerenovus 03/2021
A Prospective, Multicenter, Randomized, Controlled Pivotal Trial to Evaluate the Safety and Effectiveness of Transcatheter Mitral Valve Repair with the Edwards PASCAL Transcatheter ...... Contract $141,792.00 Clinical Trial Ashish Pershad COM Phx Internal Medicine Edwards Lifesciences LLC 06/2020
A Prospective, Randomized, Open-Label, Comparative Study to Assess the Efficacy, Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI) and Best Available Therapy for the Treatment of Serious... Contract $240,575.50 Clinical Trial Bellal Joseph Surgery Parexel International Corporation 03/2020
A Randomized Clinical Trial of Andexanet Alfa in Acute Intracranial Hemorrhage in Patients Receiving an Oral Factor Xa Inhibitor Contract $535,294.50 Clinical Trial Bellal Joseph Surgery Portola Pharmaceuticals, Inc. 03/2021
A Randomized Controlled Trial to Improve Mother-Infant Synchrony Among Women with Childhood Adversity Grant $2,437,784.00 Research Aleeca Bell College of Nursing National Institute of Nursing Research 09/2020
A Randomized Phase 3 Study to Evaluate the Efficacy and Safety of Enzastaurin Plus R-CHOP Versus R-CHOP in Treatment-Naive Subjects with High-Risk Diffuse Large B-Cell Lymphoma Who Possess the Novel.. Contract $327,830.00 Clinical Trial Abhijeet Kumar Cancer Center Division Covance, Incorporated 01/2020
A Randomized Phase 3, Double-Blind Study of Chemotherapy With or Without Pembrolizumab Followed by Maintenance With Olaparib or Placebo for the First- Line Treatment of BRCA Non-Mutated Advanced... Contract $100,897.00 Clinical Trial Setsuko Chambers Cancer Center Division GOG Foundation, Inc. 08/2020
A Randomized, Double Blind, Parallel-Group, Placebo Controlled Study to Evaluate the Efficacy and Safety of IBP-9414 in Premature Infants 500-1500g Birth Weight in the Prevention of Necrotizing... Contract $1,019,895.00 Clinical Trial Ranjit Kylathu Pediatrics Infant Bacterial Therapeutics AB (SWEDEN) 01/2021
A Randomized, Double-blind Dose-ranging, Placebo-controlled Phase 2a Evaluation of the Safety, Tolerability and Pharmacokinetics of PLN-74809 in Participants With Idiopathic Pulmonary Fibrosis (Ipf).. Contract $119,271.00 Clinical Trial Marilyn Glassberg Csete COM Phx Internal Medicine Pliant Therapeutics, Inc. 04/2021
A Randomized, Double-Blind Placebo-Controlled, Phase 3 Study of Debio 1143 in Combination with Platinum-Based Chemotherapy and Standard Fractionation Intensity-Modulated Radiotherapy in Patients with Contract $840,502.68 Clinical Trial Ricklie Julian Cancer Center Division Syneos Health 01/2021
A Randomized, Double-Blind, Parallel Group, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of Once Weekly Subcutaneous Injections of a Sustained-Release VIP Analogue, PB1046, in Adult Contract $345,225.92 Clinical Trial Franz Rischard Medicine PhaseBio Pharmaceuticals, Inc. 01/2021
A Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy and Safety of Pulsed, Inhaled Nitric Oxide (iNO) Versus Placebo in Subjects With Mild or Moderate Coronavirus Disease (Covid Contract $503,260.68 Clinical Trial Jarrod Mosier Dept of Emergency Medicine Pharmaceutical Research Associates 08/2020
A Randomized, Double-Blind, Placebo Controlled Study to Assess the Efficacy and Safety of Pulsed, Inhaled Nitric Oxide (iNO) Versus Placebo in Subjects with Mild to Moderate Coronavirus Disease... Contract $502,490.72 Clinical Trial Thomas Ardiles COM Phx Internal Medicine Pharmaceutical Research Associates 07/2020
A Randomized, Double-blind, Placebo-Controlled Clinical Trial of Fluconazole as Early Empiric Treatment of Coccidioidomycosis Pneumonia (Valley Fever) in Adults Presenting with Community Acquired ... Contract $593,373.00 Other Sponsored Activity John Galgiani Valley Fever Ctr for Excellnc Duke University 03/2021
A Randomized, Double-blind, Placebo-controlled Clinical Trial of Fluconazole as Early Empiric Treatment of Coccidioidomycosis Pneumonia (Valley Fever) in Adults Presenting with Community Acquired... Contract $593,373.00 Clinical Trial John Galgiani Valley Fever Ctr for Excellnc Duke University 06/2020
A Randomized, Double-Blind, Placebo-Controlled, Active Comparator Phase 2/3 study of Tucatinib in Combination with Trastuzumab, Ramucirumab, and Paclitaxel in Subjects with Previously Treated, Locally Contract $453,804.20 Clinical Trial Aaron Scott Cancer Center Division Seagen Inc. 01/2021
A Randomized, Double-blind, Placebo-controlled, Clinical Trial of LY3127804 in Patients who are Hospitalized with Pneumonia and Presumed or Confirmed COVID-19 Contract $1,181,507.00 Clinical Trial Jarrod Mosier Dept of Emergency Medicine Target Health, LLC 10/2020
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Tocilizumab in Hospitalized Patients with COVID-19 Pneumonia Contract $3,236,387.50 Clinical Trial Sachin Chaudhary Medicine Syneos Health 06/2020
A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of XEN1101 as Adjunctive Therapy in Focal-onset Epilepsy, with an Open Label... Contract $107,762.52 Clinical Trial David Labiner Neurology NCGS Incorporated 03/2020
A Randomized, Double-blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of LY3819253 in Participants with Mild to Moderate COVID-19 Illness Contract $1,003,039.00 Clinical Trial Jarrod Mosier Dept of Emergency Medicine Eli Lilly and Company 09/2020
A Randomized, Double-Blind, Placebo-controlled, Single-ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of JK07 in Subjects with Heart Failure with Reduced Ejection Fra... Contract $606,162.95 Clinical Trial Nancy Sweitzer Sarver Heart Center Salubris Biotherapeutics 01/2021
A Randomized, Multi-center, Phase 3 Study of Nivolumab in Combination with Ipilimumab Compared to Sorafenib or Lenvatinib as First-Line Treatment in Participants with Advanced Hepatocellular Carcinoma Contract $242,423.80 Clinical Trial Rachna Shroff Cancer Center Division Syneos Health 06/2021
A Randomized, Phase 2 Study of Stereotactic Body Radiation Therapy (SBRT) in Combination with GC4711 in the Treatment of Unresectable or Borderline Resectable, Nonmetastatic Pancreatic Cancer Contract $239,544.80 Clinical Trial Uma Goyal Cancer Center Division Galera Therapeutics, LLC 05/2021
A Randomized, Phase 3 Study of Eryaspase in Combination with Chemotherapy versus Chemotherapy Alone as Second-Line Treatment in Patients with Pancreatic Adenocarcinoma (TRYbeCA-1 - TRial of ErYaspase Contract $664,687.53 Clinical Trial Hani Babiker Cancer Center Division PPD Investigator Services, LLC. 05/2020

Pages